AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28568169
Drug: Dexamethasone (DEX)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DEX) 0.05 mg/kg IM q24h
Trial: 28568169
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone (FLUT) 3,000 μg q12h
Trial: 19389262
Drug: Acupuncture and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture and placebo medicine
Trial: 19389262
Drug: Sham acupuncture
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham acupuncture and Flunarizine (10 mg once per night for the first 2 weeks, then 5 mg once per night for the next 2 weeks)
Trial: 18181333
Drug: HIV vaccine
RxNorm normalized name: AAV-2 HIV Vaccine
DrugBank: TGAAC09 (DB06363)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV vaccine trial with education and risk reduction counseling every six months
Trial: 9674806
Drug: Nimodipine 60
RxNorm normalized name: nimodipine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine 60 mg p.o., five times daily
Trial: 9674806
Drug: Nimodipine 30
RxNorm normalized name: nimodipine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine 30 mg p.o., three times daily
Trial: 7985514
Drug: Acetaminophen in
RxNorm normalized name: acetaminophen Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen in Tibetan
Trial: 7985514
Drug: Acetaminophen in
RxNorm normalized name: acetaminophen Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen in Han
Trial: 2692576
Drug: Oral immunostimulant
RxNorm normalized name: IMMUNOSTIMULANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunostimulant
Trial: 31415908
Drug: GLP-1 RA
RxNorm normalized name: RAS
DrugBank: Rasagiline (DB01367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: GLP-1 RA exenatide (acute administration)
Trial: 31415908
Drug: GLP-1 RA
RxNorm normalized name: RAS
DrugBank: Rasagiline (DB01367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: GLP-1 RA liraglutide (titrated up to 1.8 mg daily for 12 weeks)
Trial: 26354385
Drug: Long-term domiciliary
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term domiciliary oxygen therapy (LTDOT) for more than 15 hours every day with continuous low flow (1-2 L/min) for 3 years
Trial: 26354385
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no additional oxygen therapy)
Trial: 23333143
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg/day for 9 days
Trial: 21529841
Drug: NFKB1 (g.-24519delATTG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NFKB1 (g.-24519delATTG) variant
Trial: 21529841
Drug: NFKBIA (g.-1004A>G)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NFKBIA (g.-1004A>G) variant
Trial: 17132302
Drug: Placebo (vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (vaccine diluent)
Trial: 22201658
Drug: Telephone calls
RxNorm normalized name: Mosco Corn & Callus Remover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone calls from a peer counselor once weekly for five weeks beginning six weeks postsurgery
Trial: 24521107
Drug: Mebendazole (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mebendazole (500 mg)
Trial: 12883542
Drug: Twice-weekly supervised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly supervised exercise training
Trial: 3753363
Drug: Spironolactone (S)
RxNorm normalized name: Spironolactone
DrugBank: Spironolactone (DB00421)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spironolactone (S) 25 mg orally, four times per day
Trial: 27609408
Drug: benralizumab 30
RxNorm normalized name: benralizumab 30 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benralizumab 30 mg Q4W
Trial: 27609408
Drug: benralizumab 30
RxNorm normalized name: benralizumab 30 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benralizumab 30 mg Q8W
Trial: 12649124
Drug: SCH55700 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH55700 1.0 mg/kg
Trial: 12649124
Drug: SCH55700 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH55700 0.3 mg/kg
Trial: 11194275
Drug: Bupropion (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion (300 mg delayed release for 7 to 9 weeks)
Trial: 18595418
Drug: Bupropion plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion plus nicotine patch
Trial: 30561264
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (simvastatin + ezetimibe)
Trial: 24408305
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg ISU303
Trial: 24408305
Drug: 1.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/kg ISU303
Trial: 22115011
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ezetimibe/simvastatin 10/20mg (C)
Trial: 16504368
Drug: Tibolone (Livial)
RxNorm normalized name: TIBOLONE
DrugBank: Tibolone (DB09070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone (Livial) 2.5 mg/day + Alendronate sodium (Fosamax) 10 mg/day
Trial: 16504368
Drug: Alendronate sodium
RxNorm normalized name: Alendronate Sodium
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate sodium (Fosamax) 10 mg/day
Trial: 9354202
Drug: 1-week triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-week triple therapy of omeprazole 20 mg b.d., clarithromycin 250 mg b.d. and tetracycline 500 mg b.d. (OCT)
Trial: 9354202
Drug: 2-week dual
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 2-week dual therapy of omeprazole 20 mg b.d. and amoxycillin 1 g b.d. (OA)
Trial: 9354202
Drug: Retreatment with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retreatment with OCT therapy after OA failure
Trial: 9354202
Drug: Overall success
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall success rate for triple and dual therapy sequence
Trial: 9354202
Drug: Overall success
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall success rate for dual followed by triple therapy
Trial: 8250615
Drug: Colchicine (0.6‐1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (0.6‐1.8 mg/day)
Trial: 3457171
Drug: 1.23% acidulated
RxNorm normalized name: Nupro APF 1.23% Acidulated Phosphate Fluoride Gel (Bubblegum)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.23% acidulated phosphate fluoride gel
Trial: 11253275
Drug: 0.05% sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% sodium fluoride solution
Trial: 3457171
Drug: 0.2% sodium
RxNorm normalized name: Dextrose 5% and 0.2% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% sodium fluoride solution
Trial: 30390943
Drug: Intraperitoneal carboplatin
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraperitoneal carboplatin (AUC 6) every 3 weeks with intravenous paclitaxel weekly at 80 mg/m2
Trial: 30390943
Drug: Intraperitoneal carboplatin
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraperitoneal carboplatin and intravenous paclitaxel
Trial: 26956031
Drug: Assigned treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assigned treatment
Trial: 24127851
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics with single-dose i.v. cefazolin (1 g)
Trial: 24127851
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics with single-dose i.v. ceftriaxone (1 g)
Trial: 24127851
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics with oral levofloxacin (500 mg)
Trial: 24127851
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics (all types)
Trial: 22736124
Drug: Non-antibiotics restriction
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-antibiotics restriction group
Trial: 22736124
Drug: Bowel preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bowel preparation group
Trial: 22736124
Drug: Antibiotic restriction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic restriction group
Trial: 18377127
Drug: MET plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MET plus cognitive-behavioral therapy (CBT)
Trial: 16898079
Drug: r-hIL-18 BP
RxNorm normalized name: (R)-p-mentha-1,8-diene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r-hIL-18 BP (20, 70, 210 or 350 mg, sc)
Trial: 16898079
Drug: r-hIL-18 BP
RxNorm normalized name: (R)-p-mentha-1,8-diene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r-hIL-18 BP (35 or 175 mg, sc, 6 injections, 48 h apart)
Trial: 16898079
Drug: r-hIL-18 BP
RxNorm normalized name: (R)-p-mentha-1,8-diene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r-hIL-18 BP (20, 160 or 320 mg, sc tiw)
Trial: 16898079
Drug: r-hIL-18 BP
RxNorm normalized name: (R)-p-mentha-1,8-diene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r-hIL-18 BP (20, 80, 160 mg, sc tiw)
Trial: 14593351
Drug: Bisoprolol (1.25‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol (1.25‐10 mg/day)
Trial: 1335442
Drug: L-carnitine during
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine during ECC
Trial: 1335442
Drug: L-carnitine before
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine before and during ECC
Trial: 25335251
Drug: Comprehensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive therapy group (electroacupuncture at qi streets acupoints combined with spinal regulation method)
Trial: 31930890
Drug: Comprehensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive therapy group
Trial: 25335251
Drug: Comprehensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive therapy group and medication group
Trial: 23910646
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg/day with peginterferon alfa plus ribavirin
Trial: 12788962
Drug: Long-acting β2-agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting β2-agonists (salmeterol or formoterol) used as second-line treatment for 1 week or more
Trial: 11105182
Drug: Antiemetic pharmacotherapy
RxNorm normalized name: metoclopramide
DrugBank: Metoclopramide (DB01233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antiemetic pharmacotherapy alone
Trial: 8731623
Drug: Hospital treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital treatment and education/advice
Trial: 1574950
Drug: Simvastatin 10‐40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10‐40 mg/day
Trial: 26401946
Drug: Serum lutein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum lutein (L) concentrations
Trial: 23273405
Drug: Fluticasone/formoterol 250/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone/formoterol 250/10 μg b.i.d.
Trial: 19278300
Drug: 375 μg
RxNorm normalized name: penicillin G 375 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 375 μg interferon-β-1b
Trial: 19278300
Drug: 250 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 μg interferon-β-1b
Trial: 11691573
Drug: Isepamicin at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isepamicin at 7.5 mg/kg i.v. q 12 h
Trial: 11691573
Drug: Amikacin at
RxNorm normalized name: Amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin at 7.5 mg/kg i.v. q 12 h
Trial: 8131769
Drug: Captopril, 25
RxNorm normalized name: Captopril, 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril, 25 mg three times daily
Trial: 24711481
Drug: Patients who
RxNorm normalized name: MAYZENT 0.25mg Tablet Starter Pack (For Patients Who Will Receive The 2mg Maintenance Dosage)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients who experienced syncope post pacemaker implant
Trial: 23078636
Drug: Temptation to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temptation to drink (self-reported measure during the fourth session of treatment)
Trial: 14599997
Drug: Tiredness in
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiredness in daily activities (measured by questionnaire surveys)
Trial: 11072443
Drug: Carbidopa/levodopa (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbidopa/levodopa (25 mg carbidopa and 100 mg levodopa, one tablet TID for 1 week, 1 1/2 tablets TID for 1 week, then two tablets TID for 6 weeks)
Trial: 8773860
Drug: 1 mg.kg-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg.kg-1 ketorolac i.v.
Trial: 8773860
Drug: 1.5 mg.kg-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg.kg-1 codeine im
Trial: 1335644
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine lot 1
Trial: 1335644
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine lot 2
Trial: 1335644
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine lot 3
Trial: 1335644
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine lots 1, 2, and 3
Trial: 6138083
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg triazolam
Trial: 6138083
Drug: 9 mg
RxNorm normalized name: fiber 469 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9 mg alpha-hydroxy midazolam
Trial: 6138083
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg alpha-hydroxy triazolam
Trial: 6138083
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg 4-hydroxy triazolam
Trial: 31209630
Drug: Scrambler Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scrambler Therapy
Trial: 11279797
Drug: Autologous tumor
RxNorm normalized name: DNP-Modified autologous tumor vaccine
DrugBank: DNP-Modified autologous tumor vaccine (DB17436)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous tumor cell vaccines (10 million irradiated tumor cells with various adjuvants, weekly x3 and then monthly x5)
Trial: 11279797
Drug: Autologous tumor
RxNorm normalized name: DNP-Modified autologous tumor vaccine
DrugBank: DNP-Modified autologous tumor vaccine (DB17436)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous tumor cell vaccines
Trial: 9644824
Drug: Concurrent articulation
RxNorm normalized name: follicle stimulating hormone / luteinizing hormone Injection [Menopur]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent articulation during the serial report task
Trial: 9644824
Drug: Concurrent tapping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent tapping during the serial report task
Trial: 3062604
Drug: Triamterene-containing preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triamterene-containing preparation
Trial: 11684372
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol 50 microg/die for 12 cycles
Trial: 11684372
Drug: Placebo patches
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patches for 12 cycles
Trial: 11049919
Drug: Low-flow sevoflurane
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-flow sevoflurane anesthesia (1 L/min)
Trial: 27413741
Drug: High-flow sevoflurane
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-flow sevoflurane anesthesia (4 L/min)
Trial: 23268736
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral vitamin D3 dose (70,000 IU)
Trial: 19887137
Drug: ACWY-TT conjugate
RxNorm normalized name: Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACWY-TT conjugate vaccine
Trial: 16045141
Drug: Low-dose intravenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intravenous ketamine (0.15 mg kg(‐1))
Trial: 1902253
Drug: Low-dose intravenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intravenous ketamine
Trial: 11819728
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (Group A)
Trial: 12394893
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (Group B)
Trial: 10363198
Drug: Double therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double therapy (interferon alpha + oral ribavirin)
Trial: 10363198
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (interferon alpha + oral ribavirin + oral amantadine)
Trial: 8881849
Drug: Transdermal oestrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal oestrogen patch releasing 50 micrograms oestradiol 24 h-1
Trial: 26401247
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron therapy
Trial: 26648450
Drug: Topical coenzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical coenzyme Q10-containing formulas
Trial: 19715381
Drug: Fentanyl buccal
RxNorm normalized name: Fentanyl Buccal Film
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl buccal soluble film (FBSF) pH 6
Trial: 19715381
Drug: Fentanyl buccal
RxNorm normalized name: Fentanyl Buccal Film
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl buccal soluble film (FBSF) pH 7.25
Trial: 19715381
Drug: Fentanyl buccal
RxNorm normalized name: Fentanyl Buccal Film
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl buccal soluble film (FBSF) pH 8.5
Trial: 17890356
Drug: Fixed contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed contrast material dose (120 mL of iohexol 300) at an injection rate of 4.0 mL/sec (Protocol 1)
Trial: 17890356
Drug: Dose tailored
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose tailored to patient's body weight (2.0 mL/kg) injected over 30 seconds (Protocol 2)
Trial: 14999221
Drug: PT-141 (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PT-141 (4 mg)
Trial: 14999221
Drug: PT-141 (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PT-141 (6 mg)
Trial: 14999221
Drug: PT-141 (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PT-141 (0.3 to 10 mg)
Trial: 11146577
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (HRT) with transdermal estrogen with or without progestogen
Trial: 11146577
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen with and without progestogen
Trial: 9832298
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone (2 mg x kg(‐1)) during the acute phase
Trial: 9832298
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (2 mg x kg(‐1)) during the acute phase
Trial: 9832298
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (2 mg x kg(‐1)) after remission
Trial: 8077885
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide 1.2 mg day-1 to 2.0 mg day-1 (n = 9)
Trial: 2812839
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g of lactulose
Trial: 2812839
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g of lactulose (placebo)
Trial: 12443672
Drug: Oral killed
RxNorm normalized name: Hongo Killer
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral killed cholera vaccine
Trial: 779998
Drug: Oral live
RxNorm normalized name: polio vaccine, oral live
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral live cholera vaccine